U01AG055133
Cooperative Agreement
Overview
Grant Description
Motrpac: UC preclinical animal study site.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Iowa City,
Iowa
52242
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 11/30/22 to 11/30/24 and the total obligations have increased 11367% from $23,550 to $2,700,584.
Oklahoma Medical Research Foundation was awarded
MoTrPAC: UC Preclinical Animal Study Site
Cooperative Agreement U01AG055133
worth $2,700,584
from the National Institute of Allergy and Infectious Diseases in December 2016 with work to be completed primarily in Iowa City Iowa United States.
The grant
has a duration of 8 years and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).
Status
(Complete)
Last Modified 4/21/25
Period of Performance
12/15/16
Start Date
11/30/24
End Date
Funding Split
$2.7M
Federal Obligation
$0.0
Non-Federal Obligation
$2.7M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01AG055133
Transaction History
Modifications to U01AG055133
Additional Detail
Award ID FAIN
U01AG055133
SAI Number
U01AG055133-311149154
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NN00 NIH National Insitute on Aging
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
NGCNCJ1X6XA4
Awardee CAGE
4X200
Performance District
IA-01
Senators
Charles Grassley
Joni Ernst
Joni Ernst
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Office of the Director, National Institutes of Health, Health and Human Services (075-0846) | Health research and training | Grants, subsidies, and contributions (41.0) | $3,110,535 | 97% |
Modified: 4/21/25